1089209-14-2Relevant academic research and scientific papers
Novel design principle validated: Glucopyranosylidene-spiro-oxathiazole as new nanomolar inhibitor of glycogen phosphorylase, potential antidiabetic agent
Somsak, Laszlo,Nagy, Veronika,Vidal, Sebastien,Czifrak, Katalin,Berzsenyi, Eszter,Praly, Jean-Pierre
experimental part, p. 5680 - 5683 (2009/06/18)
2-Naphthyl-substituted glucopyranosylidene-spiro-oxathiazole prepared following a novel design principle was found to be the best known glucose analogue inhibitor of rabbit muscle glycogen phosphorylase b (Ki 160 nM).
